David L. Yarian

Cost-Utility Comparison of Bevacizumab and Aflibercept in the Treatment of Central or Hemiretinal Vein Occlusion in the SCORE2 Trial

Steven Kymes, Neal L. Oden, Paul VanVeldhuisen, Ingrid U. Scott et autres

Importance: Retinal vein occlusion is the second most common retinal vascular disease. Bevacizumab was demonstrated in the Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) to be noninferior to aflibercept with respect to visual acuity in study participants with macular …

us (code pays fourni par la source)

Baseline Characteristics and Outcomes After Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion

Ingrid U. Scott, Neal L. Oden, Paul VanVeldhuisen, Michael S. Ip et autres

Importance: Intravitreal anti-vascular endothelial growth factor (VEGF) injections are commonly used to treat eyes with macular edema secondary to hemiretinal vein occlusion (HRVO) or central retinal vein occlusion (CRVO). Information on whether differences exist in outcomes after anti-VEGF therapy can help guide …

us (code pays fourni par la source)

Intraocular Pressure–Related Events After Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion

Ahmad A. Aref, Ingrid U. Scott, Paul VanVeldhuisen, Jacquie King et autres

IMPORTANCE: Intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections are used to treat a variety of posterior segment conditions, including some associated with glaucoma, such as macular edema due to central retinal vein occlusion (CRVO). Therefore, information regarding intraocular pressure (IOP)-related events associated …

us (code pays fourni par la source)

One-Year Follow Up Results of Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema (DME) in Highly Treated Eyes

Nisha Dhawlikar, Sumit P. Shah, David L. Yarian, Jonathan L. Prenner et autres

us (code pays fourni par la source)

Short Term Results of Fluocinolone Acetonide Intravitreal Implant (Iluvien®) for Diabetic Macular Edema in Highly Treated Eyes

Nisha Dhawlikar, Sumit P. Shah, David L. Yarian, Jonathan L. Prenner et autres

us (code pays fourni par la source)

Prospective study on antimicrobial resistance rates following repeated courses of topical antibiotics for intravitreal injection

Tahia Haque, Thomas Kirn, Daniel B. Roth, Sumit P. Shah et autres

us (code pays fourni par la source)

The Incidence of Noninfectious Intraocular Inflammation after Intravitreal Aflibercept Injection

Kunjal K Modi, Daniel B. Roth, Howard F. Fine, H. Matthew Wheatley et autres

us (code pays fourni par la source)

Tantric sexuality education.

David L. Yarian

Intravitreal Triamcinolone Acetonide Injections in the Treatment of Retinal Vein Occlusions

Daniel B. Roth, Catherine A. Cukras, Ravi S. Radhakrishnan, William J. Feuer et autres

BACKGROUND AND OBJECTIVE: To report the visual acuity response after intravitreal triamcinolone injection in patients with macular edema due to retinal vein occlusions. PATIENTS AND METHODS: Retrospective nonrandomized interventional series of 172 consecutive patients with macular edema due to retinal vein occlusions …

us (code pays fourni par la source)

SHORT-TERM COMPLICATIONS OF INTRAVITREAL INJECTION OF TRIAMCINOLONE ACETONIDE

Daniel B. Roth, Tony Realini, William J. Feuer, Ravi S. Radhakrishnan et autres

In Brief Purpose: To describe the short-term complications associated with intravitreal triamcinolone acetonide (IVTA) injection in the treatment of posterior segment disorders. Methods: The medical records of 784 patients (929 consecutive eyes) were retrospectively reviewed at a single institution. One or more …

us (code pays fourni par la source)

MICROPULSED LASER PHOTOCOAGULATION AND INTRAVITREAL TRIAMCINOLONE ACETONIDE INJECTION FOR THE TREATMENT OF RETINAL ANGIOMATOUS PROLIFERATION

Daniel B. Roth, Ingrid U. Scott, J.M. Gloth, Stuart N. Green et autres

PURPOSE: To investigate visual acuity and fluorescein angiographic outcomes, as well as adverse events, associated with treatment of retinal angiomatous proliferation (RAP) with micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection. METHODS: In this retrospective, noncomparative, interventional, consecutive case series, the medical …

us (code pays fourni par la source)

Early Clinical Experience with Pegaptanib Sodium (Macugen) in Age–Related Macular Degeneration

Daniel B. Roth, Jonathan L. Prenner, S.N. Green, David L. Yarian et autres

us (code pays fourni par la source)